Home
Alinamin Pharmaceutical

Alinamin Pharmaceutical Market Share Analysis for November 2025

説明アリナミン製薬株式会社は、OTC医薬品や健康食品等の製造・販売を行う日本の製薬会社である。ウィキペディア

Health > Biotechnology and Pharmaceuticals

Domainalinamin-pharma.co.jp

Year Founded--

Employees501 - 1000

Annual Revenue--

Alinamin Pharmaceutical

Alinamin Pharmaceutical (including company regionals)

alinamin-pharma.co.jp

See more website traffic and engagement information

Total visits to Alinamin Pharmaceutical's top domains

Understand Alinamin Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alinamin-pharma.co.jp13.7K

See more with Sales Intelligence

Avg. visit duration in Alinamin Pharmaceutical's top domains

Analyze Alinamin Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alinamin-pharma.co.jp00:00:13

See more with Sales Intelligence

Avg. pageviews on Alinamin Pharmaceutical's top domains

See how Alinamin Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alinamin-pharma.co.jp1.49

See more with Sales Intelligence

Alinamin Pharmaceutical top competitors by domain

Top similar sites in November 2025, ranked by their affinity

nihon-pharm.co.jpCompany NameNihon PharmaceuticalEmployees201 - 500HQJapan, HigashikandaAnnual revenue$2M - $5MTotal visits5.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Alinamin Pharmaceutical

These are the website technologies, by industry, used by Alinamin Pharmaceutical top domains

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

Social (2)

Instagram

Audio Video Media (1)

YouTube

More Technologies

5

See all

News & Signals from Alinamin Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMBK Partners Ltd. acquires Alinamin Pharmaceutical Co.,Ltd for $2.1B.MBK Partners plans to acquire Alinamin Pharmaceutical from Blackstone to drive the Japanese consumer-healthcare company's further expansion in markets abroad.